Bicycle Therapeutics plc (BCYC)
USD 15.32
(1.16%)
USD 15.32
(1.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 26.97 Million | 14.46 Million | 11.69 Million | 10.39 Million | 13.8 Million | 7.13 Million |
| Cost of Revenue | 156.49 Million | 3.68 Million | 44.88 Million | 33.14 Million | 25.54 Million | 20.76 Million |
| Gross Profit | -129.52 Million | 10.77 Million | -33.18 Million | -22.75 Million | -11.73 Million | -13.62 Million |
| Operating Expenses | 216.92 Million | 131.11 Million | 77.31 Million | 62.35 Million | 40.1 Million | 28.88 Million |
| Selling, General and Administrative Expenses | 59.83 Million | 49.5 Million | 32.43 Million | 29.2 Million | 14.56 Million | 8.12 Million |
| Research and Development Expenses | 156.49 Million | 81.6 Million | 44.88 Million | 33.14 Million | 25.54 Million | 20.76 Million |
| Other Expenses | - | - | - | - | -5.37 Million | -665 Thousand |
| Cost and Expenses | 216.92 Million | 131.11 Million | 77.31 Million | 62.35 Million | 40.1 Million | 28.88 Million |
| Operating Income | -189.94 Million | -116.65 Million | -65.61 Million | -51.96 Million | -26.29 Million | -21.74 Million |
| Interest Expense | 3.26 Million | 3.34 Million | 2.98 Million | 457 Thousand | - | - |
| Income Tax Expense | 1.45 Million | -1.52 Million | -1.66 Million | -724 Thousand | -254 Thousand | -396 Thousand |
| Earnings before Tax | -179.2 Million | -114.24 Million | -68.48 Million | -51.73 Million | -30.86 Million | -22.24 Million |
| Net Income | -180.66 Million | -112.71 Million | -66.81 Million | -51.01 Million | -30.6 Million | -21.84 Million |
| Earnings Per Share Basic | -5.08 | -3.80 | -2.67 | -2.66 | -2.77 | -1.64 |
| Earnings Per Share Diluted | -5.08 | -3.80 | -2.67 | -2.66 | -2.77 | -1.64 |
| Weighted Average Shares Outstanding | 35.59 Million | 29.66 Million | 25.06 Million | 19.14 Million | 11.04 Million | 13.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.59 Million | 29.66 Million | 25.06 Million | 19.14 Million | 11.04 Million | 13.29 Million |
| Gross Margin | -4.80 | 0.75 | -2.84 | -2.19 | -0.85 | -1.91 |
| EBIT Margin | -6.80 | -7.67 | -5.60 | -4.94 | -1.91 | -2.95 |
| Profit Margin | -6.70 | -7.79 | -5.71 | -4.91 | -2.22 | -3.06 |
| EBITDA | -183.4 Million | -112.96 Million | -64.08 Million | -50.38 Million | -30.02 Million | -21.49 Million |
| Earnings Before Tax Margin | -7.04 | -8.07 | -5.61 | -5.00 | -1.91 | -3.05 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.67 Million | 9.37 Million | 19.51 Million | 26.97 Million | 5.33 Million | 5.35 Million |
| Cost of Revenue | 2.19 Million | 1.64 Million | 1.65 Million | 6.57 Million | 1.66 Million | 1.68 Million |
| Gross Profit | 481.72 Thousand | 7.72 Million | 17.86 Million | 20.4 Million | 3.66 Million | 3.67 Million |
| Operating Expenses | 66.52 Million | 61.84 Million | 65.31 Million | 216.32 Million | 59.74 Million | 55.43 Million |
| Selling, General and Administrative Expenses | 18.25 Million | 14.42 Million | 15.13 Million | - | 15.05 Million | 15.56 Million |
| Research and Development Expenses | 48.26 Million | 47.42 Million | 50.18 Million | - | 44.69 Million | 39.86 Million |
| Other Expenses | - | -47.36 Million | - | - | - | - |
| Cost and Expenses | 66.52 Million | 63.48 Million | 66.96 Million | 216.32 Million | 59.74 Million | 55.43 Million |
| Operating Income | -63.84 Million | -54.11 Million | -47.44 Million | -189.94 Million | -54.23 Million | -50.79 Million |
| Interest Expense | -33 Thousand | 824 Thousand | 821 Thousand | 3.26 Million | 820 Thousand | 814 Thousand |
| Income Tax Expense | -3.44 Million | -7.2 Million | -15.68 Million | 1.45 Million | 320 Thousand | 2.27 Million |
| Earnings before Tax | -54.25 Million | -47.05 Million | -42.23 Million | -179.2 Million | -48.77 Million | -47.62 Million |
| Net Income | -50.8 Million | -39.85 Million | -26.54 Million | -180.66 Million | -49.09 Million | -49.89 Million |
| Earnings Per Share Basic | -0.74 | -0.77 | -0.62 | - | -1.16 | -1.26 |
| Earnings Per Share Diluted | -0.74 | -0.77 | -0.62 | - | -1.16 | -1.26 |
| Weighted Average Shares Outstanding | 68.98 Million | 51.99 Million | 42.56 Million | 35.59 Million | 42.41 Million | 39.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 68.98 Million | 51.99 Million | 42.56 Million | 35.59 Million | 42.41 Million | 39.57 Million |
| Gross Margin | 0.18 | 0.82 | 0.92 | 0.76 | 0.69 | 0.69 |
| EBIT Margin | -23.86 | -5.60 | -2.35 | - | -8.72 | -8.30 |
| Profit Margin | -18.98 | -4.25 | -1.36 | -6.70 | -9.21 | -9.32 |
| EBITDA | -63.84 Million | -52.47 Million | -45.79 Million | - | -46.48 Million | -44.4 Million |
| Earnings Before Tax Margin | -23.86 | -5.77 | -2.43 | -7.04 | -10.17 | -9.49 |
060980
LSPKF
LIS
REXR-PB
NESCO
013570